Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 04:00PM ET
10.56
Dollar change
+0.49
Percentage change
4.87
%
IndexRUT P/E- EPS (ttm)-5.53 Insider Own0.85% Shs Outstand25.91M Perf Week-4.52%
Market Cap273.61M Forward P/E- EPS next Y-3.21 Insider Trans0.00% Shs Float25.69M Perf Month30.86%
Income-124.94M PEG- EPS next Q-1.10 Inst Own16.99% Short Float7.92% Perf Quarter9.09%
Sales0.72M P/S380.01 EPS this Y27.34% Inst Trans46.74% Short Ratio5.45 Perf Half Y30.47%
Book/sh4.04 P/B2.61 EPS next Y27.53% ROA-63.15% Short Interest2.04M Perf Year62.96%
Cash/sh4.08 P/C2.59 EPS next 5Y41.50% ROE-85.09% 52W Range3.89 - 14.75 Perf YTD72.55%
Dividend Est.- P/FCF- EPS past 5Y13.49% ROI-118.19% 52W High-28.40% Beta0.89
Dividend TTM- Quick Ratio4.77 Sales past 5Y60.80% Gross Margin-333.87% 52W Low171.60% ATR (14)0.75
Dividend Ex-Date- Current Ratio4.77 EPS Y/Y TTM53.05% Oper. Margin-16868.62% RSI (14)57.97 Volatility8.52% 7.88%
Employees122 Debt/Eq0.14 Sales Y/Y TTM-92.95% Profit Margin-17423.44% Recom2.00 Target Price19.70
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q30.69% Payout- Rel Volume0.61 Prev Close10.07
Sales Surprise-100.00% EPS Surprise-29.28% Sales Q/Q-100.00% EarningsMay 13 AMC Avg Volume373.51K Price10.56
SMA2014.24% SMA506.24% SMA20029.32% Trades Volume229,639 Change4.87%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Stephens Overweight $20
Jan-25-24Upgrade Oppenheimer Perform → Outperform $4
Nov-09-22Downgrade Maxim Group Buy → Hold
Nov-01-22Downgrade BofA Securities Neutral → Underperform $2
Jul-19-22Resumed RBC Capital Mkts Sector Perform $5 → $4
May-11-22Downgrade Oppenheimer Outperform → Perform
Jan-21-22Upgrade BofA Securities Underperform → Neutral $8 → $10
Dec-29-21Resumed Jefferies Hold $8 → $6
Sep-10-21Downgrade BofA Securities Neutral → Underperform $9 → $8
Jun-24-21Initiated Jefferies Hold $9
Jul-12-24 10:09AM
09:28AM
Jul-11-24 08:00AM
Jul-02-24 04:05PM
Jul-01-24 04:00PM
08:00AM Loading…
08:00AM
Jun-04-24 08:00AM
May-31-24 04:48PM
May-22-24 09:45AM
May-14-24 08:21AM
07:55AM
03:02AM
May-13-24 09:45PM
08:55PM
04:28PM
04:05PM Loading…
04:05PM
May-05-24 08:54AM
May-01-24 08:00AM
Apr-29-24 08:00AM
08:00AM
Apr-15-24 06:39PM
Mar-26-24 06:28PM
Mar-08-24 09:55AM
Mar-07-24 10:38AM
06:39AM
Mar-06-24 11:30PM
09:54PM
04:05PM
07:00AM
Feb-21-24 09:55AM
08:00AM Loading…
08:00AM
Feb-12-24 06:25AM
Feb-07-24 11:46AM
Feb-02-24 08:00AM
Jan-30-24 09:55AM
Jan-24-24 09:13AM
Jan-23-24 08:00AM
Jan-22-24 08:00AM
Jan-12-24 09:43AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Nov-14-23 10:56AM
Nov-10-23 03:38PM
12:00AM
Nov-09-23 04:42PM
04:05PM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 09:53AM
Oct-10-23 08:00AM
Sep-28-23 11:10AM
Sep-27-23 07:39PM
Sep-07-23 08:00AM
Sep-06-23 09:31PM
Aug-29-23 08:00AM
Aug-09-23 08:30PM
05:40PM
04:38PM
04:05PM
Aug-04-23 08:00AM
Jul-26-23 09:32AM
Jun-23-23 04:10PM
Jun-01-23 08:00AM
May-25-23 08:00AM
May-23-23 04:13PM
May-15-23 12:00PM
06:08AM
May-13-23 08:20AM
May-12-23 06:14AM
May-11-23 03:30AM
May-10-23 05:45PM
04:05PM
May-08-23 08:00AM
May-05-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-26-23 08:00AM
Apr-17-23 01:55PM
08:00AM
Apr-13-23 02:07PM
Apr-12-23 08:00AM
Apr-04-23 03:10PM
Apr-03-23 08:00AM
Mar-06-23 01:07AM
Mar-03-23 08:00AM
Mar-01-23 07:00PM
06:15PM
04:05PM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-03-23 08:00AM
Feb-02-23 01:39PM
08:00AM
Feb-01-23 01:55PM
Jan-31-23 11:40AM
11:07AM
08:00AM
Jan-03-23 07:27AM
Nov-18-22 11:42AM
11:02AM
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.